Intellego Receives Notice To Grant Patent On Photochromic Ink Technology.

Intellego Technologies receives notice to grant for a patent related to the breakthrough development of its photochromic Ink technology:

 We are delighted to announce another milestone for Intellego Technologies: the UK patent office is granting a patent application for our photochromic ink, the core technology in our dosimeter design. This achievement fortifies the protection of our core technology and further strengthens Intellego’s position as a global leader in the UV industry until 2042.

The international recognition of our patent, validated through identical PCT and UK search reports, marks a milestone moment for Intellego. This acknowledgement strengthens our commitment to pushing the boundaries of ink technology internationally and enhancing our vision of ensuring that all UV technology is validated.

Our patents showcase the efforts of Dr Laila Moreno and our dedicated Research and Development team in Europe. These advancements show our commitment to continuous innovation, excellence and precision, ensuring our technology remains at the forefront of the industry.

Claes Lindahl, our CEO, emphasised the strategic importance of enhancing Intellego’s intellectual property protection. He stated, “Expanding Intellego’s IP protection is crucial for growing our business, especially with larger international partners and customers where IP protection is paramount.”

Impacts On Our Industries:

Intellego Healthcare:

Intellego’s photochromic ink, already an integral part of dosimeter cards, continues to gain traction in the healthcare sector. Beyond its current applications, the ink echoes the necessity for validating all UV technology in healthcare settings. Our ink and dosimeter cards are essential tools that prove the effectiveness of UV technology in reducing healthcare-associated infections (HAIs), further enhancing safety protocols in medical environments. Our dosimeters provide healthcare facilities with peace of mind, knowing that their staff and patients are protected with an improved disinfection routine.

Intellego Curing:

In the UV curing industry, our ink brings about a transformative change. Factories and manufacturing facilities utilising UV technology continue to benefit from an accurate and precise quality assurance step. This development elevates the efficiency and reliability of UV curing processes, ensuring the production of high-quality goods across various industries. With our patent comes an increased component, allowing our photochromic ink to delay the onset of colour change to extend the exposure window. This allows a higher range of wavelength indicators, as seen in the launch of our 395 range of dosimeters.

Elle Lacey, our COO and CMO said ‘”The patent grant for Intellego’s technology sets a new standard in UV technology validation, marking our commitment to enhance global business and industry efficiencies. We’re leading the charge to ensure every UV technology meets the highest validation standards, driving innovation and superior outcomes worldwide.”